These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 10995972)

  • 21. Cold ischemia time and MHC class II matching in renal transplants.
    Iwaki Y; Cicciarelli J; Aswad S; Gavazov M; Obispo E; Khetan U; Bogaard T; Asai P; Mendez RG; Mendez R
    Transplant Proc; 1992 Dec; 24(6):2456-7. PubMed ID: 1465829
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of recipient's HLA type on the outcome of renal transplantation.
    Forsberg B; Ekberg H; Johnson U
    Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
    [No Abstract]   [Full Text] [Related]  

  • 23. Weak humoral posttransplant alloresponse after a well-HLA-matched cadaveric kidney transplantation.
    Matinlauri IH; Kyllönen LE; Eklund BH; Koskimies SA; Salmela KT
    Transplantation; 2004 Jul; 78(2):198-204. PubMed ID: 15280678
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recipient sensitization against donor cells in pre- and/or posttransplantation sera is inversely correlated with graft survival.
    Sumitran S; Forsberg I; Lindholm A; Lundgren G; Möller E
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1566-7. PubMed ID: 3274384
    [No Abstract]   [Full Text] [Related]  

  • 25. Beneficial effect of DR matching on cadaveric renal graft survival in Scandiatransplant.
    Leivestad T; Berger L; Thorsby E
    Transplant Proc; 1992 Dec; 24(6):2447-8. PubMed ID: 1465824
    [No Abstract]   [Full Text] [Related]  

  • 26. [The role of expression of histocompatibility antigens class II (HLA-D) and interleukin-2 receptor in the process of rejection of transplanted organs. I].
    Nowaczyk M
    Pol Arch Med Wewn; 1989; 82(4-6):190-4. PubMed ID: 2518392
    [No Abstract]   [Full Text] [Related]  

  • 27. Nonradioactive DNA/RFLP analysis for HLA DR and DQ allotypes.
    Crosby I; Beales P; Barnes RM
    Transplant Proc; 1992 Dec; 24(6):2481-2. PubMed ID: 1361259
    [No Abstract]   [Full Text] [Related]  

  • 28. Pretransplant and posttransplant monitoring of anti-HLA class I IgG1 antibodies by ELISA identifies patients at high risk of graft loss.
    Monteiro F; Mineiro C; Rodrigues H; de Paula FJ; Kalil J
    Transplant Proc; 1997; 29(1-2):1433-4. PubMed ID: 9123368
    [No Abstract]   [Full Text] [Related]  

  • 29. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
    Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
    Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
    [No Abstract]   [Full Text] [Related]  

  • 30. Influence of pretransplant antibodies on early renal allograft rejection.
    Alarif L; Rodriguez R; Blackburn S; Light JA
    Transplant Proc; 1987 Feb; 19(1 Pt 1):771-2. PubMed ID: 3274869
    [No Abstract]   [Full Text] [Related]  

  • 31. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of MICA antigens on kidney transplantation outcomes.
    Luo L; Li Z; Wu W; Luo G; Mei H; Sun Z; Xu C
    Immunol Lett; 2013; 156(1-2):54-8. PubMed ID: 24004718
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA typing on peripheral blood lymphocytes from cadaveric donors to reduce cold ischemia.
    Muñoz C; Franco A; Prados MC; de la Sen ML; Perdiguero M; Olivares J
    Transplant Proc; 1992 Dec; 24(6):2490-1. PubMed ID: 1465840
    [No Abstract]   [Full Text] [Related]  

  • 34. Association of high HLA-E expression during acute cellular rejection and numbers of HLA class I leader peptide mismatches with reduced renal allograft survival.
    Guberina H; Rebmann V; Wagner B; da Silva Nardi F; Dziallas P; Dolff S; Bienholz A; Wohlschlaeger J; Bankfalvi A; Heinemann FM; Witzke O; Zoet YM; Claas FH; Horn PA; Kribben A; Doxiadis II
    Immunobiology; 2017 Mar; 222(3):536-543. PubMed ID: 27871782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of the MHC-encoded HLA-DMA, DMB, and LMP2 gene polymorphisms on kidney graft outcome.
    Chevrier D; Giral M; Muller JY; Bignon JD; Soulillou JP
    Hum Immunol; 1998 Oct; 59(10):650-5. PubMed ID: 9757947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Allosensitization to HLA and MICA is an important measure of renal graft outcome.
    Panigrahi A; Siddiqui JA; Rai A; Margoob A; Khaira A; Bhowmik D; Tiwari SC; Guleria S; Mehra NK
    Clin Transpl; 2007; ():211-7. PubMed ID: 18637472
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Abrogation of anti-HLA antibodies via proteasome inhibition.
    Trivedi HL; Terasaki PI; Feroz A; Everly MJ; Vanikar AV; Shankar V; Trivedi VB; Kaneku H; Idica AK; Modi PR; Khemchandani SI; Dave SD
    Transplantation; 2009 May; 87(10):1555-61. PubMed ID: 19461494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of HLA and race on long-term cadaveric renal transplantation.
    Bryan CF; Aeder MI; Helling TS; Hughes J; Luger AM; Nelson PW; Pierce GE; Shield CF; Warady B
    Transplant Proc; 1992 Dec; 24(6):2451-3. PubMed ID: 1465826
    [No Abstract]   [Full Text] [Related]  

  • 39. Human leukocyte antigen and major histocompatibility complex class I-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients.
    Seyhun Y; Ozdilli K; Oguz F; Karahan G; Onal E; Turkmen A; Eldegez U; Nane I; Çalişkan Y; Bakkaloglu H; Carin M
    Transplant Proc; 2012; 44(6):1660-6. PubMed ID: 22841239
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of race, PRA level, and gender on the incidence of a positive donor-specific preliminary T cell crossmatch.
    Bryan CF; Aeder MI; Helling TS; Luger AM; Nelson PW; Pierce GE; Shield CF; Thomas A
    Transplant Proc; 1992 Dec; 24(6):2517-8. PubMed ID: 1465851
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.